GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bcworldpharm Co Ltd (XKRX:200780) » Definitions » Debt-to-Asset

Bcworldpharm Co (XKRX:200780) Debt-to-Asset : 0.50 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Bcworldpharm Co Debt-to-Asset?

Bcworldpharm Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩78,865 Mil. Bcworldpharm Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩11,378 Mil. Bcworldpharm Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was ₩180,331 Mil. Bcworldpharm Co's debt to asset for the quarter that ended in Mar. 2024 was 0.50.


Bcworldpharm Co Debt-to-Asset Historical Data

The historical data trend for Bcworldpharm Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bcworldpharm Co Debt-to-Asset Chart

Bcworldpharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 - 0.50 0.52 0.50

Bcworldpharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.50 0.49 0.50 0.50

Competitive Comparison of Bcworldpharm Co's Debt-to-Asset

For the Drug Manufacturers - General subindustry, Bcworldpharm Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bcworldpharm Co's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bcworldpharm Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Bcworldpharm Co's Debt-to-Asset falls into.



Bcworldpharm Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Bcworldpharm Co's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(79845.663 + 11994.877) / 184110.789
=0.50

Bcworldpharm Co's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(78865.468 + 11377.739) / 180331.223
=0.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bcworldpharm Co  (XKRX:200780) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Bcworldpharm Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Bcworldpharm Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Bcworldpharm Co (XKRX:200780) Business Description

Traded in Other Exchanges
N/A
Address
78, Gaepo-ro 22-gil, Gangnam-gu, Seoul, KOR
Bcworldpharm Co Ltd is a pharmaceutical company. The Company's products include Anti-TB, Anti-Diabetic, Analgesics, Narcotics Antidotes and Hemostatics. The products are offered under ALIMA Inj, AROXOL Tab, ASCORBIC Inj and BC CITICOLINE Inj brands.

Bcworldpharm Co (XKRX:200780) Headlines

No Headlines